ES2374392T3 - Proteínas de metaloproteasa. - Google Patents

Proteínas de metaloproteasa. Download PDF

Info

Publication number
ES2374392T3
ES2374392T3 ES03782702T ES03782702T ES2374392T3 ES 2374392 T3 ES2374392 T3 ES 2374392T3 ES 03782702 T ES03782702 T ES 03782702T ES 03782702 T ES03782702 T ES 03782702T ES 2374392 T3 ES2374392 T3 ES 2374392T3
Authority
ES
Spain
Prior art keywords
human
polypeptide
nucleic acid
disease
clontech
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03782702T
Other languages
English (en)
Spanish (es)
Inventor
Richard Joseph Fagan
Christopher Benjamin Phelps
Christine Power
Richard James Mitter
Ursula Boschert
Yolande Chvatchko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Trading SA
Original Assignee
Ares Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SA filed Critical Ares Trading SA
Application granted granted Critical
Publication of ES2374392T3 publication Critical patent/ES2374392T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
ES03782702T 2002-12-23 2003-12-23 Proteínas de metaloproteasa. Expired - Lifetime ES2374392T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0230006 2002-12-23
GBGB0230006.9A GB0230006D0 (en) 2002-12-23 2002-12-23 Proteins
PCT/GB2003/005664 WO2004056983A2 (en) 2002-12-23 2003-12-23 Metalloprotease proteins

Publications (1)

Publication Number Publication Date
ES2374392T3 true ES2374392T3 (es) 2012-02-16

Family

ID=9950313

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03782702T Expired - Lifetime ES2374392T3 (es) 2002-12-23 2003-12-23 Proteínas de metaloproteasa.

Country Status (11)

Country Link
US (1) US7557079B2 (enExample)
EP (1) EP1583825B1 (enExample)
JP (1) JP5053516B2 (enExample)
AT (1) ATE526400T1 (enExample)
AU (1) AU2003290342B2 (enExample)
CA (1) CA2510066A1 (enExample)
ES (1) ES2374392T3 (enExample)
GB (1) GB0230006D0 (enExample)
IL (1) IL169256A (enExample)
NO (1) NO20053575L (enExample)
WO (1) WO2004056983A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100183617A1 (en) * 2005-02-23 2010-07-22 University Of Virginia Patent Foundation Compositions and methods for regulating sas1r
GB0921001D0 (en) 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
CN109957557B (zh) * 2017-12-26 2023-01-06 广州市锐博生物科技有限公司 Dna聚合酶及其制备方法
CN114032252B (zh) * 2021-11-01 2022-04-22 武汉爱博泰克生物科技有限公司 一种重组状态人源mmp-7蛋白的表达方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166902A1 (en) * 2001-02-20 2003-09-04 Yi Hu Novel human protease and polynucleotides encoding the same
JP2004508021A (ja) 2000-08-23 2004-03-18 アプレラ　コーポレーション 単離ヒトプロテアーゼタンパク質、ヒトプロテアーゼタンパク質をコード化する核酸分子及びその使用
CA2459140A1 (en) 2001-09-14 2003-03-27 Incyte Genomics, Inc. Protein modification and maintenance molecules

Also Published As

Publication number Publication date
CA2510066A1 (en) 2004-07-08
EP1583825A2 (en) 2005-10-12
AU2003290342B2 (en) 2009-09-24
JP2006516888A (ja) 2006-07-13
WO2004056983A3 (en) 2006-02-09
JP5053516B2 (ja) 2012-10-17
GB0230006D0 (en) 2003-01-29
ATE526400T1 (de) 2011-10-15
EP1583825B1 (en) 2011-09-28
US7557079B2 (en) 2009-07-07
US20060252117A1 (en) 2006-11-09
IL169256A0 (en) 2007-07-04
NO20053575L (no) 2005-09-23
IL169256A (en) 2010-11-30
NO20053575D0 (no) 2005-07-21
WO2004056983A2 (en) 2004-07-08
AU2003290342A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
US20020065406A1 (en) 18221, a novel dual specificity phosphatase and uses thereof
AU2012358384A1 (en) Methods of increasing the viability or longevity of an organ or organ explant
US6416974B1 (en) Tango 71 nucleic acids
US20030215820A1 (en) Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
JP2002511233A (ja) Ｔｒｅｋ１様の２孔カリウムチャネル
US6358707B1 (en) Human F11 antigen: a novel cell surface receptor involved in platelet aggregation
US20040241805A1 (en) Sialoadhesin family member-2 (SAF-2)
ES2306802T3 (es) Proteina de pliegue con nudo de cistina.
US6716613B1 (en) Metalloprotease having aggrecanase activity
EP0921197A2 (en) Human disintegrin metalloprotease related to drosophila kuz gene
ES2374392T3 (es) Proteínas de metaloproteasa.
ES2352339T3 (es) Proteínas defensinas.
US6274717B1 (en) Splicing variant of human membrane-type matrix metalloproteinease-5 (MT-MMP5-L)
ES2292449T3 (es) 17867, una aminopeptidasa humana novedosa.
US7160693B2 (en) Human hydrolase family members and uses thereof
US6716614B1 (en) Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
ES2330868T3 (es) Proteina que contiene dominio mam.
US6214600B1 (en) Membrane-type matrix metalloproteinase-5 gene
CA2405078A1 (en) Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
US20020183269A1 (en) Novel compounds
ES2319104T3 (es) Adenilato ciclasa humana.
JP2000515762A (ja) 新規なヒトｍＲＮＡ校正酵素
US20030166899A1 (en) ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
US20030148306A1 (en) Aggrecanase molecules
ES2338317T3 (es) Variante de corte y empalme de la hormona hipofisaria humana del crecimiento.